MedinCell S.A. ( MDCLF) - Key Metrics
MDCLF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q2 | $0.32 | -$0.50 | $0.74 | $0.73 |
| 2024Q4 | $0.13 | -$0.58 | -$0.01 | -$0.01 |
| 2024Q2 | $0.25 | -$0.29 | -$0.47 | -$0.49 |
| 2023Q4 | $0.15 | -$0.72 | -$0.40 | -$0.43 |
MDCLF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q2 | ? | -7.83 |
| 2024Q4 | ? | -4.17 |
| 2024Q2 | ? | -5.47 |
| 2023Q4 | ? | -3.39 |
MDCLF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q2 | 4.68% | ? |
| 2024Q4 | -0.12% | ? |
| 2024Q2 | -7.58% | ? |
| 2023Q4 | -4.36% | ? |
MDCLF
Price: $34.39
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.72 USD
P/E Ratio: -47.76
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.2 billion